More Business Wire
View Older Stories View Newer Stories-
Standard Nuclear First to Receive HALEU Feedstock for Production of TRISO Fuel to Support 2026 Reactor Demonstration
-
CFDA and Ralph Lauren Announce Two New Grant Programs to Strengthen American Fashion Manufacturing
-
Horizon3.ai Appoints Andres Botero as Chief Marketing Officer to Drive Strategic Growth and Category Leadership
-
Better Home & Finance Holding Company to Participate in the 28th Annual Needham Growth Conference
-
LoneTree Welcomes Gerald Castaldo as Partner
-
Valley Bank Strengthens Local Communities with $106,000 Investment in Education
-
eGenesis to Present at 44th Annual J.P. Morgan Healthcare Conference
-
Soley Therapeutics Announces $200 Million Series C Financing to Propel Lead Oncology Programs into the Clinic and Scale Its Cell Stress Sensing Platform
-
WP Engine Acquires Big Bite
-
Immuto Scientific Announces Research Collaboration with a Leading US-Based Multinational Animal Health Company
-
Ascidian Therapeutics and Forge Biologics Announce Manufacturing Partnership to Advance RNA Editing Therapy for Stargardt Disease
-
Blackstone Announces Additional Investment in AIR Control Concepts
-
Forlong Biotechology Announced Activation of Phase Ib/II Study of FL115 (IL-15 Superagonist) in combination with anti-PD-1 Antibody for Patients with Advanced Solid Tumor and Acceptance of IND for FL1
-
Wells Fargo to Announce Fourth Quarter 2025 Earnings on Jan. 14, 2026
-
Poplar Therapeutics Launches With $50M Series A to Advance a New Class of Anti-IgE Therapy for Multiple Atopic Conditions
-
Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
-
SPG Expands Operations with New Guadalajara Manufacturing Facility
-
FDA and EMA Grant Orphan Drug Designation for Curadel’s CPI-008, a Targeted Zwitterionic Imaging Drug for Pancreatic Cancer
-
Adapture Renewables Closes $233 Million in Financing from U.S. Bank for Titanium Solar Projects in Illinois and Arkansas
-
RingCentral Appoints Mahmoud ElAssir to Board of Directors
-
CFEX Launches Billing Solution to Monetize the Whole AI Stack from Watts to Bits to Tokens
-
Crypto.com Completes Integration to Lynq; Aquanow, DV Chain, GSR, Nonco, and Wintermute, First to Post Off Exchange Collateral via Lynq Network Streamlining Institutional Exchange Funding
-
Universal Announces New $20 Million Share Repurchase Authorization
-
Albertsons® Companies, Inc. Reports Third Quarter Fiscal 2025 Results
-
Nuevocor Appoints Al Gianchetti as Chief Executive Officer
-
XCharge North America and Energy Plus Partner to Build One of the Largest Battery-Backed EV Charging Depots in the U.S.
-
Arrowhead Pharmaceuticals Announces NMPA Approval of REDEMPLO® (plozasiran) for Familial Chylomicronemia Syndrome (FCS) in China
-
CoStar Group Provides Full Year 2026 and Medium-Term Outlook with Significant Adjusted EBITDA Expansion
-
ATL Partners Acquires SkyMark and Rampmaster to Create a Leading Specialty Vehicle Equipment Platform Serving the Aviation and Transportation-Related End Markets
-
Tradeweb Reports December 2025 Total Trading Volume of $63.0 Trillion and Average Daily Volume of $2.8 Trillion
-
NRG Energy Announces Leadership Succession Plan
-
Superior Health Holdings Expands Louisiana Hospice Footprint with Acquisition of Hope Healthcare & Hospice (Bayou Country)
-
Dominion Energy Schedules Fourth-Quarter 2025 Earnings Call
-
Valvoline Instant Oil Change Breaks Records as It Raises $1.8 Million for Children’s Miracle Network Hospitals
-
Albertsons® Companies Announces Common Stock Dividend
-
BXP and Starr Announce Lease Signing at BXP’s 343 Madison Avenue in Midtown Manhattan
-
CareDx and 10x Genomics to Launch ImmuneScape™ Program – A Multiomics Research Platform to Decode Transplant Rejection and Drug Response
-
Healthpeak Properties Announces the Formation of a Pure-Play, RIDEA-Structured Publicly Traded Senior Housing REIT
-
Zeitro Introduces Scenario AI for Mortgage Origination
-
EA Pharma, a subsidiary of Eisai, Announces the Initiation of its Phase III Clinical Trial with Evenamide, a Novel Treatment for Schizophrenia, in Japan
-
PlusAI to Bolster Board in Connection with Public Listing
-
Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
-
SAGA Diagnostics® Presents Real-World Pathlight™ MRD Data at ASCO GI 2026
-
QwikOS Debuts World's First Universal Humanoid Operating System and App Store
-
SharkNinja Appoints Jason Wortendyke to Its Board of Directors
-
Lattice Semiconductor to Present at the 28th Annual Needham Growth Conference
-
LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
-
Healthpeak Properties Announces Confidential Submission of Draft Registration Statement by Janus Living, Inc.
-
D-Wave Announces Agreement to Acquire Quantum Circuits Inc., Establishing World’s Leading Quantum Computing Company
-
PlusAI to Participate in Upcoming Investor Conference
